^ ab“Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer”. Gastroenterology128 (5): 1160–71. (2005). doi:10.1053/j.gastro.2005.01.056. PMID15887099.
^“CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues”. Medicina (Kaunas)49 (8): 361–6. (2013). PMID24509146.
^“Promoter methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir valley”. Asian Pac. J. Cancer Prev.13 (8): 4177–81. (2012). doi:10.7314/apjcp.2012.13.8.4177. PMID23098428.
^“Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene”. Am J Otolaryngol32 (6): 528–36. (2011). doi:10.1016/j.amjoto.2010.11.005. PMID21353335.
^“Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma”. Otolaryngol Head Neck Surg141 (4): 484–90. (2009). doi:10.1016/j.otohns.2009.07.007. PMID19786217.
^“Methylation profiling of archived non-small cell lung cancer: a promising prognostic system”. Clin. Cancer Res.11 (12): 4400–5. (2005). doi:10.1158/1078-0432.CCR-04-2378. PMID15958624.
^Rubin H (March 2011). “Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture”. BioEssays33 (3): 224–31. doi:10.1002/bies.201000067. PMID21254148.
^“Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array”. Neurosci. Lett.409 (2): 112–7. (2006). doi:10.1016/j.neulet.2006.09.038. PMID17034947.
^“Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer”. Gastric Cancer6 (2): 86–95. (2003). doi:10.1007/s10120-003-0213-z. PMID12861399.
^ abcd“Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over”. Nat. Genet.13 (3): 336–42. (1996). doi:10.1038/ng0796-336. PMID8673133.
^“Comparative analysis of meiotic progression in female mice bearing mutations in genes of the DNA mismatch repair pathway”. Biol. Reprod.78 (3): 462–71. (2008). doi:10.1095/biolreprod.107.065771. PMID18057311.
^“The Bloom's syndrome protein (BLM) interacts with MLH1 but is not required for DNA mismatch repair”. J. Biol. Chem.276 (32): 30031–5. (August 2001). doi:10.1074/jbc.M009664200. PMID11325959.
^“The interaction of DNA mismatch repair proteins with human exonuclease I”. J. Biol. Chem.276 (35): 33011–8. (August 2001). doi:10.1074/jbc.M102670200. PMID11427529.
^ ab“Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX”. Oncogene22 (6): 819–25. (February 2003). doi:10.1038/sj.onc.1206252. PMID12584560.
^“The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer”. J. Biol. Chem.274 (10): 6336–41. (March 1999). doi:10.1074/jbc.274.10.6336. PMID10037723.
関連文献
“Clinicopathological relevance of the association between gastrointestinal and sebaceous neoplasms: the Muir-Torre syndrome.”. Hum. Pathol.26 (4): 422–7. (1995). doi:10.1016/0046-8177(95)90144-2. PMID7705822.
“The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer.”. International Journal of Colorectal Disease22 (7): 739–48. (2007). doi:10.1007/s00384-006-0228-0. PMID17109103.